Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Application of human umbilical cord blood-derived mesenchymal stem cells in disease models.

Literature DB >> 21607114

Application of human umbilical cord blood-derived mesenchymal stem cells in disease models.

Ju-Yeon Kim¹, Hong Bae Jeon, Yoon Sun Yang, Wonil Oh, Jong Wook Chang.

Abstract

Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) are regarded as an alternative source of bone marrow-derived mesenchymal stem cells because collection of cord blood is less invasive than that of bone marrow. hUCB-MSCs have recently been studied for evaluation of their potential as a source of cell therapy. In this review, the general characteristics of hUCB-MSCs and their therapeutic effects on various diseases in vitro and in vivo will be discussed.

Entities: Species

Keywords: Immune modulation; Mesenchymal stem cells; Nursing effect; Regeneration

Year: 2010 PMID： 21607114 PMCID： PMC3097922 DOI： 10.4252/wjsc.v2.i2.34

Source DB: PubMed Journal: World J Stem Cells ISSN： 1948-0210 Impact factor: 5.326

34 in total

1. Pluripotency of mesenchymal stem cells derived from adult marrow.

Authors: Yuehua Jiang; Balkrishna N Jahagirdar; R Lee Reinhardt; Robert E Schwartz; C Dirk Keene; Xilma R Ortiz-Gonzalez; Morayma Reyes; Todd Lenvik; Troy Lund; Mark Blackstad; Jingbo Du; Sara Aldrich; Aaron Lisberg; Walter C Low; David A Largaespada; Catherine M Verfaillie
Journal: Nature Date: 2002-06-20 Impact factor: 49.962

Review 2. Umbilical cord blood-derived stem cells and brain repair.

Authors: Paul R Sanberg; Alison E Willing; Svitlana Garbuzova-Davis; Samuel Saporta; Guoqing Liu; Cyndy Davis Sanberg; Paula C Bickford; Stephen K Klasko; Nagwa S El-Badri
Journal: Ann N Y Acad Sci Date: 2005-05 Impact factor: 5.691

3. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

Authors: Amelia Bartholomew; Cord Sturgeon; Mandy Siatskas; Karen Ferrer; Kevin McIntosh; Sheila Patil; Wayne Hardy; Steve Devine; David Ucker; Robert Deans; Annemarie Moseley; Ronald Hoffman
Journal: Exp Hematol Date: 2002-01 Impact factor: 3.084

4. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.

Authors: Akira Nakamizo; Frank Marini; Toshiyuki Amano; Asadullah Khan; Matus Studeny; Joy Gumin; Julianne Chen; Stephen Hentschel; Giacomo Vecil; Jennifer Dembinski; Michael Andreeff; Frederick F Lang
Journal: Cancer Res Date: 2005-04-15 Impact factor: 12.701

5. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness.

Authors: Shaul Beyth; Zipora Borovsky; Dror Mevorach; Meir Liebergall; Zulma Gazit; Hadi Aslan; Eithan Galun; Jacob Rachmilewitz
Journal: Blood Date: 2004-10-28 Impact factor: 22.113

6. Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis.

Authors: Yong Wook Park; Young Mo Kang; Joe Butterfield; Michael Detmar; Jörg J Goronzy; Cornelia M Weyand
Journal: Am J Pathol Date: 2004-12 Impact factor: 4.307

7. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.

Authors: Katarina Le Blanc; Charlotte Tammik; Kerstin Rosendahl; Eva Zetterberg; Olle Ringdén
Journal: Exp Hematol Date: 2003-10 Impact factor: 3.084

8. Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood.

Authors: Eun Ji Gang; Ju Ah Jeong; Seung Hyun Hong; Soo Han Hwang; Seong Whan Kim; Il Ho Yang; Chiyoung Ahn; Hoon Han; Hoeon Kim
Journal: Stem Cells Date: 2004 Impact factor: 6.277

9. Human umbilical cord blood-derived stromal cells suppress xenogeneic immune cell response in vitro.

Authors: Lei Hao; Cheng Zhang; Xing-Hua Chen; Zhong-Min Zou; Xi Zhang; Pei-Yan Kong; Xue Liang; Lei Gao; Xian-Gui Peng; Ai-Hua Sun; Qing-Yu Wang
Journal: Croat Med J Date: 2009-08 Impact factor: 1.351

Review 10. Graft-versus-host disease: emerging concepts in prevention and therapy.

Authors: Robert M Dean; Michael R Bishop
Journal: Curr Hematol Rep Date: 2003-07

33 in total

1. Ensheathing cell-conditioned medium directs the differentiation of human umbilical cord blood cells into aldynoglial phenotype cells.

Authors: María Dolores Ponce-Regalado; Daniel Ortuño-Sahagún; Carlos Beas Zarate; Graciela Gudiño-Cabrera
Journal: Hum Cell Date: 2012-04-21 Impact factor: 4.174

Review 2. Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds.

Authors: Giovanni Marfia; Stefania Elena Navone; Clara Di Vito; Nicola Ughi; Silvia Tabano; Monica Miozzo; Carlo Tremolada; Gianni Bolla; Chiara Crotti; Francesca Ingegnoli; Paolo Rampini; Laura Riboni; Roberta Gualtierotti; Rolando Campanella
Journal: Organogenesis Date: 2015 Impact factor: 2.500

3. GDF-15 secreted from human umbilical cord blood mesenchymal stem cells delivered through the cerebrospinal fluid promotes hippocampal neurogenesis and synaptic activity in an Alzheimer's disease model.

Authors: Dong Hyun Kim; Dahm Lee; Eun Hyuk Chang; Ji Hyun Kim; Jung Won Hwang; Ju-Yeon Kim; Jae Won Kyung; Sung Hyun Kim; Jeong Su Oh; Sang Mi Shim; Duk Lyul Na; Wonil Oh; Jong Wook Chang
Journal: Stem Cells Dev Date: 2015-08-19 Impact factor: 3.272

10. Comparison of human umbilical cord blood-derived mesenchymal stem cells with healthy fibroblasts on wound-healing activity of diabetic fibroblasts.

Authors: Jae-A Jung; Young-Don Yoon; Hyup-Woo Lee; So-Ra Kang; Seung-Kyu Han
Journal: Int Wound J Date: 2017-11-07 Impact factor: 3.315